Import Ayush Kwath — Buy in wholesale FOB from Supplier in India

Ayush Kwath is a proprietary Ayurvedic herbal blend manufactured by Athrav Pharmaceutical Pvt. Ltd. in New Delhi, India, combining Tulsi (Ocimum sanctum) leaf and Cinnamon (Cinnamomum cassia) bark as its primary actives. The formulation follows the classical Ayurvedic Kwath preparation method, where dried herbs are processed into a concentrated decoction form suitable for bulk industrial use. The supplier specifies GMP-certified batch production with moisture-proof export packaging and a 24-month shelf life, positioning it as a raw material for immunity-focused product manufacturers.

The Tulsi component provides eugenol, rosmarinic acid and ursolic acid, compounds with documented adaptogenic and respiratory-support properties in traditional medicine literature. Cinnamon contributes cinnamaldehyde and proanthocyanidins, offering antimicrobial and metabolic modulation effects typical of Cinnamomum cassia bark extracts. The formulation omits Ginger (Zingiber officinale) and Black Pepper (Piper nigrum) as primary ingredients despite their mention in marketing materials, these appear as secondary or promotional inclusions rather than core actives. Standard Ayush Kwath preparations in the Indian market typically contain 40-50% Tulsi by dry weight, with Cinnamon at 20-30%, though Athrav Pharmaceutical does not publish exact blend ratios.

Primary buyers include nutraceutical contract manufacturers, functional beverage companies and wellness brands formulating immunity-positioned products for European, North American and Southeast Asian markets. The decoction format suits further processing into sachets, liquid shots, capsules or base extracts for finished goods. Importers should verify phytochemical standardisation protocols, heavy metal testing per Indian Pharmacopoeia limits, and organic certification status if marketing to regulated markets. The GMP certification claim requires direct verification, as response rate data shows no confirmed buyer engagement through standard channels.

Athrav Pharmaceutical Pvt. Ltd. operates from a second-floor facility at Plot No 24 [--] [the address indicates a commercial office location in Dwarka, New Delhi, rather than a manufacturing plant]. The company holds a 'harbor' trust tier classification, which represents a baseline verification level on its host platform. The response rate shows 0.00% with zero average response hours, meaning no buyer inquiries through standard channels have received confirmed replies。<br><br>The listing presents itself as a supplier of Ayurvedic raw materials with GMP-certified production, though the relationship between Athrav Pharmaceutical and the actual manufacturing site is unclear from available data. The product description mixes genuine herbal knowledge with promotional content (notably the 'free hand sanitizer' offer, which suggests retail or small-batch positioning inconsistent with bulk B2B supply). No information is provided about years in operation, factory ownership, export licence numbers, or existing client base. The supplier's address in Delhi's Dwarka sector places it within India's National Capital Region pharmaceutical cluster, but importers should verify manufacturing capacity, third-party audit status, and whether GMP certification applies to the specific Ayush Kwath product or to a broader facility scope.